Spectrometric Assessment of Generic and Brand Drug Quality for a Sentinel Screening Network-Reference-Cited by-同舟云学术

Spectrometric Assessment of Generic and Brand Drug Quality for a Sentinel Screening Network

Published:2023-07-20 Issue:8 Volume:77 Page:915-927
ISSN:0003-7028
Container-title:Applied Spectroscopy
language:en
Short-container-title:Appl Spectrosc

Author:

Isaacs James T.¹,Almeter Philip J.¹²,Henderson Bradley S.¹,Hunter Aaron N.¹,Platt Thomas L.¹,Lodder Robert A.³^ORCID

Affiliation:

1. Department of Pharmacy Services, University of Kentucky, Lexington, Kentucky, USA

2. Pharmacy Practice and Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA

3. Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky, USA

Abstract

The U.S. Food and Drug Administration (FDA) is a worldwide leader among analogous regulatory organizations in other countries. The FDA uses current good manufacturing practices to regulate the processes that produce drugs. Nevertheless, investigative journalists have pointed out problems in the drug supply, and pharmacies are not required to test the drugs they receive. The University of Kentucky Drug Quality Study does perform screening on the sterile injectable drugs that it receives and regularly reports new findings to FDA, practitioners, and the public. A Sentinel Screening Network of academic health systems could provide independent data on drug quality to FDA not available through manufacturers.

Funder

Center for Scientific Review

Publisher

SAGE Publications

Subject

Spectroscopy,Instrumentation

Link

http://journals.sagepub.com/doi/pdf/10.1177/00037028231184478

Reference18 articles.

1. FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug Supply

2. U.S. National Archives and Records Administration Office, Office of the Federal Register. “An Act of June 30, 1906, Public Law 59-384, 34 STAT 768, for Preventing the Manufacture, Sale, or Transportation of Adulterated or Misbranded or Poisonous or Deleterious Foods, Drugs, Medicines, and Liquors, and for Regulating Traffic Therein, and for Other Purposes: Pure Food and Drug Act”. https://catalog.archives.gov/id/5716297 [accessed Jan 3 2023].

3. U.S. Government Printing Office. “Kefauver–Harris Amendment to the Federal Food, Drug, and Cosmetic Act”. Pub L. No. 87–781, 1962. https://www.govinfo.gov/content/pkg/STATUTE-76/pdf/STATUTE-76-Pg780.pdf [accessed Jan 3 2023].

4. U.S. National Research Council. “Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs: Food and Drug Administration”. Washington, DC: The National Academies Press, 1969. https://nap.nationalacademies.org/download/24615# [accessed Jan 3 2023].